Etten-Leur, Tokyo, Moscow, June 9, 2021. R-Pharm Group announces the signing of a distribution agreement with PHC Europe B.V., one of the largest suppliers of biopharmaceutical and medical equipment, formerly known as Panasonic Biomedical Sales Europe B.V..
The agreement provides for R-Pharm to register and promote in Russia, Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Uzbekistan and Ukraine its high-tech refrigeration equipment, biotech incubators, climate chambers and an entire line of equipment for laboratories, biotech facilities, and medical institutions.
PHCbi refrigeration equipment covers a temperature range from +23 to -150 ℃, making it possible to store all known types of vaccines and biologics, as well as blood and its components. It is important to note that the PHC refrigeration equipment is designed not only for medical institutions, but also for research laboratories and biopharmaceutical production. As of today, R-Pharm’s production sites have already purchased more than 20 units of equipment to support the vaccine project.
Denis Cherednichenko, Vice-President for Medical Systems at R-Pharm Group:
We welcome the agreement between R-Pharm and PHC Europe B.V. coming into force. It represents an important milestone in the development of the strategic partnership between Russia and Japan. Regarding the organization of this cooperation, I would like to mention the efforts of Mitsui & Co., Ltd. , a shareholder of both companies for active assistance and support in establishing partnerships between PHC Europe B.V. and R-Pharm.The introduction of modern PHCbi equipment to the market will significantly expand technological capabilities both of the healthcare system and the pharmaceutical industry, including in combatting COVID-19.
Michaël Diesveld, General manager at PHC Europe:
PHC Europe B.V. is proud to make an agreement with such an important player at pharmaceutical, medical, and laboratory market as R-Pharm Group. This agreement makes it possible to offer our state-of-the-art products and applications to a wider range of researchers, in clinics, pharmaceutical companies and research institutes.